Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
New and evolving concepts in the neurotoxicology of lead
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New and evolving concepts in the neurotoxicology of lead'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glucose-regulated Protein 78 (GRP78)
100%
Neurotoxicology
100%
Chaperone
75%
Interleukin-6
50%
Astrocytes
50%
Hippocampus
50%
Rodents
50%
Cognitive Deficits
50%
Nervous System
50%
Synaptic Plasticity
50%
Structural Plasticity
50%
Cellular Models
50%
Alzheimer's Disease Pathology
25%
Alzheimer's Disease
25%
Adult Neurogenesis
25%
Adverse Effects
25%
Neurodegeneration
25%
Learning Impairment
25%
Amyloid beta
25%
Long-term Potentiation
25%
Environmental Factors
25%
Molecular Chaperone
25%
Old Age
25%
Toxicology
25%
Later Life
25%
Low Socioeconomic Status
25%
Astroglial Cells
25%
Amyloidogenesis
25%
Pb Exposure
25%
Cell-type Specificity
25%
Targets of Interest
25%
Amyloid-β Protein Precursor (AβPP)
25%
Protein Amyloids
25%
Memory Models
25%
Xenobiotic Metals
25%
Cellular Growth
25%
Mesocorticolimbic Dopamine System
25%
Learning Model
25%
Essential Function
25%
Biological Substrates
25%
Lead Exposure
25%
Glutamate Release
25%
NMDA Receptor Function
25%
Retention Time
25%
Protein Conformational Change
25%
Glucose-regulated Protein
25%
Nervous System Development
25%
Biochemistry, Genetics and Molecular Biology
Secretion (Process)
100%
Interleukin 6
100%
Astrocyte
100%
Nervous System Development
100%
Neurotoxicology
100%
Nerve Cell Plasticity
100%
Glucocorticoid
100%
Deficiency
100%
Cytokine
50%
Amyloid Beta
50%
Amyloid Precursor Protein
50%
Cell Growth
50%
Long Term Potentiation
50%
NMDA Receptor
50%
Protein Associated with Alzheimer's Disease
50%
Retention Time
50%
Cell Specificity
50%
Glucose-Regulated Protein
50%
Glutamic Acid
50%
Lead Poisoning
50%
Chaperone Protein
50%
Neuroscience
Chaperone
100%
Neurotoxicology
100%
Glucocorticoid
66%
Astrocyte
66%
Hippocampus
66%
Alzheimer's Disease
66%
Neurogenesis
66%
Cognitive Disorders
66%
Interleukin 6
66%
Synaptic Plasticity
66%
Nervous System
66%
In Vitro
33%
Amyloid Precursor Protein
33%
Neurodegeneration
33%
Learning Disabilities
33%
Adverse Effect
33%
Beta Amyloid
33%
Long-Term Potentiation
33%
Glutamic Acid
33%
NMDA Receptor
33%
Cell Growth
33%
Glucose Regulated Protein
33%
Glucose Regulated Protein 78
33%
Cell Specificity
33%
Cytokine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chaperone
100%
Neurotoxicology
100%
Glucocorticoid
66%
Alzheimer's Disease
66%
Cognitive Defect
66%
Interleukin 6
66%
Diseases
66%
Cytokine
33%
Nerve Degeneration
33%
Glutamic Acid
33%
Amyloid Precursor Protein
33%
Glucose Regulated Protein
33%
Glucose Regulated Protein 78
33%
Learning Disorder
33%
N Methyl Dextro Aspartic Acid Receptor
33%
Amyloid Protein
33%
Lead Poisoning
33%
Toxicology
33%